Article
NRF2 upregulation by CDDO-Me protects AC16 human cardiomyocytes against doxorubicin-induced toxicity
2025-09-15
Abstract excerpt
Doxorubicin (DOX) is an effective anticancer therapeutic but exhibits dose-dependent, potentially life-threatening cardiotoxicity. The specific mechanisms driving this cardiotoxicity are not fully understood but can include the induction of oxidative stress and subsequent cell death mechanism activation. This has prompted the exploration of NRF2, a master co-ordinator of antioxidant and largely cytoprotective path...
Topics
Open a Topic to create a Post that cites this publication.
- ATP Synthase and ATPases Research
- Cancer-related cognitive impairment studies
- Cancer Treatment and Pharmacology
- Chemotherapy-induced cardiotoxicity and mitigation
- Genomics, phytochemicals, and oxidative stress
- Histone Deacetylase Inhibitors Research
- Mitochondrial Function and Pathology
- Peptidase Inhibition and Analysis
Identifiers and source
- Literature Corpus work
- 5473e7a4-f4f5-5aea-80aa-e00d85113e85
- DOI
- 10.1101/2025.09.10.675420
